Sign In
Buy OMCL
$41.89
-0.0200 (-0.0477%)
At Close: Jun 03, 2026
Omnicell (OMCL) Q4 Earnings Lag Estimates
08:46am, Thursday, 05'th Feb 2026
Omnicell (OMCL) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.6 per share a year ago.
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results
06:30am, Thursday, 05'th Feb 2026
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results.
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of “Hold” from Analysts
02:00am, Monday, 02'nd Feb 2026
Omnicell, Inc. (NASDAQ: OMCL - Get Free Report) has received an average rating of "Hold" from the eight ratings firms that are covering the company, MarketBeat Ratings reports. One equities research a
OMCL or HIMS: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 30'th Jan 2026
Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors
Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline
11:06am, Thursday, 29'th Jan 2026
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes
10:56am, Wednesday, 21'st Jan 2026
Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
Careview Communications (OTCMKTS:CRVW) & Omnicell (NASDAQ:OMCL) Critical Analysis
02:10am, Monday, 19'th Jan 2026
Omnicell (NASDAQ: OMCL - Get Free Report) and Careview Communications (OTCMKTS:CRVW - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses b
All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy
01:01pm, Tuesday, 13'th Jan 2026
Omnicell (OMCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
OMCL vs. HIMS: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 13'th Jan 2026
Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
08:01am, Tuesday, 13'th Jan 2026
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026.
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs
03:33pm, Monday, 05'th Jan 2026
6,106 shares were sold for a transaction value of $243,629 on Dec. 3, 2025. The sale represented 5.85% of direct holdings, reducing direct ownership to 98,282 shares (0.2122% of shares outstanding).
Best Momentum Stocks to Buy for Dec. 16
11:01am, Tuesday, 16'th Dec 2025
PAAS, OMCL and MDB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 16, 2025.
New Strong Buy Stocks for Dec. 16: MDB, OMCL, and More
06:46am, Tuesday, 16'th Dec 2025
COF, QCRH, TNET, MDB and OMCL have been added to the Zacks Rank #1 (Strong Buy) List on Dec. 16, 2025.
Federated Hermes Inc. Reduces Holdings in Omnicell, Inc. $OMCL
04:20am, Thursday, 11'th Dec 2025
Federated Hermes Inc. reduced its position in Omnicell, Inc. (NASDAQ: OMCL) by 20.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commissi
Omnicell, Inc. (OMCL) Discusses Launch of Titan XT Enterprise Platform and Its Impact on Pharmacy Operations Transcript
09:27pm, Monday, 08'th Dec 2025
Omnicell, Inc. (OMCL) Discusses Launch of Titan XT Enterprise Platform and Its Impact on Pharmacy Operations Transcript
